The U.S. Food and Drug Administration has issued a warning for surgical placement of mesh through the vagina to repair pelvic organ transplant. Adverse effects include tissue erosion, pain, infection, bleeding, and pain during sexual intercourse. The FDA also stated that the mesh “may expose patients to greater risk than other surgical options.” Read more.
FDA warns of risk of surgical mesh used to repair pelvic organ prolapse
The views and opinions expressed here are those of the author and do not necessarily reflect the opinions or recommendations of the American Nurses Association, the Editorial Advisory Board members, or the Publisher, Editors and staff of American Nurse Journal. This has not been peer reviewed.